The share price is disappointing. However, the potential has not changed. Will recover when trials get closer I expect.
Jacob Hope is on hold with patents being pursued. Ex CEO seemed very fond of this project and has stated reason for leaving is to pursue non oncology drug development. Join the dots...
Isn't GK about 70? Probably wants to make the most of his remaining productive years.